BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28506782)

  • 21. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.
    Botterel F; Farrugia C; Ichai P; Costa JM; Saliba F; Bretagne S
    Transpl Infect Dis; 2008 Oct; 10(5):333-8. PubMed ID: 18627580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients.
    Ku NS; Han SH; Choi JY; Kim SB; Kim HW; Jeong SJ; Kim CO; Song YG; Kim JM
    Scand J Infect Dis; 2012 Aug; 44(8):600-4. PubMed ID: 22385270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital.
    Ocansey BK; Otoo B; Gbadamosi H; Opintan JA; Dei-Adomakoh Y; Kosmidis C; Denning DW
    West Afr J Med; 2023 Jun; 40(6):613-618. PubMed ID: 37390225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
    Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies.
    Hirata Y; Yokote T; Kobayashi K; Nakayama S; Oka S; Miyoshi T; Akioka T; Hiraoka N; Iwaki K; Takayama A; Nishimura Y; Makino J; Takubo T; Tsuji M; Hanafusa T
    Leuk Lymphoma; 2010 May; 51(5):853-9. PubMed ID: 20214445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough invasive mould infections in patients treated with caspofungin.
    Pang KA; Godet C; Fekkar A; Scholler J; Nivoix Y; Letscher-Bru V; Massias L; Kauffmann-Lacroix C; Elsendoorn A; Uzunov M; Datry A; Herbrecht R
    J Infect; 2012 Apr; 64(4):424-9. PubMed ID: 22227384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
    Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
    Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational study.
    Teering S; Verreth A; Peeters A; Van Regenmortel N; De Laet I; Schoonheydt K; Dits H; Van De Vyvere M; Libeer C; Meersseman W; Malbrain ML
    Anaesthesiol Intensive Ther; 2014; 46(3):145-54. PubMed ID: 25078766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients.
    Bretagne S; Marmorat-Khuong A; Kuentz M; Latgé JP; Bart-Delabesse E; Cordonnier C
    J Infect; 1997 Jul; 35(1):7-15. PubMed ID: 9279718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.
    Maertens J; Verhaegen J; Lagrou K; Van Eldere J; Boogaerts M
    Blood; 2001 Mar; 97(6):1604-10. PubMed ID: 11238098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
    Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders.
    Suankratay C; Kanitcharaskul P; Arunyingmongkol K
    J Med Assoc Thai; 2006 Nov; 89(11):1851-8. PubMed ID: 17205865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of the Aspergillus galactomannan antigen testing for neutropenic paediatric patients.
    Sav H; Atalay MA; Koc AN; Unal E; Demir G; Zararsiz G
    Infez Med; 2017 Mar; 25(1):38-44. PubMed ID: 28353454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients.
    Choi SH; Kang ES; Eo H; Yoo SY; Kim JH; Yoo KH; Sung KW; Koo HH; Kim YJ
    Pediatr Blood Cancer; 2013 Feb; 60(2):316-22. PubMed ID: 23042761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Tănase AD; Coliţă A; Mărculescu A; Berteanu C; Streinu Cercel A; Stoica M; Stoica A; Cernea D; Copotoiu S; Brînzaniuc K; Azamfirei L
    Rom J Morphol Embryol; 2012; 53(2):379-82. PubMed ID: 22732810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.
    Maertens J; Verhaegen J; Demuynck H; Brock P; Verhoef G; Vandenberghe P; Van Eldere J; Verbist L; Boogaerts M
    J Clin Microbiol; 1999 Oct; 37(10):3223-8. PubMed ID: 10488181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of the serum galactomannan assay for the diagnosis of invasive aspergillosis in children with acute lymphoblastic leukemia.
    Avcu G; Karapinar DY; Akinci AB; Sivis ZO; Sahin A; Bal ZS; Polat SH; Metin DY; Vardar F; Aydinok Y
    Int J Infect Dis; 2017 Jan; 54():8-12. PubMed ID: 27815226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients].
    Ji Y; Liu DH; Xu LP; Liu KY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):83-6. PubMed ID: 17650666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.